The role of primary pharmacological therapy in acromegaly. - Test2 - elhamkhani - TriplyDB

The role of primary pharmacological therapy in acromegaly.

The role of primary pharmacological therapy in acromegaly.

http://www.wikidata.org/entity/Q37531005

about

Frequency of multiple endocrine neoplasia type 1 in a group of patients with pituitary adenoma: genetic study and familial screening.

P2860

Q37531060-C8F69825-EA30-40CA-AC3B-EFB5ED2B5BE7

P2860

The role of primary pharmacological therapy in acromegaly.

http://www.wikidata.org/entity/Q37531005

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The role of primary pharmacological therapy in acromegaly.

@en

The role of primary pharmacological therapy in acromegaly.

@nl

type

label

The role of primary pharmacological therapy in acromegaly.

@en

The role of primary pharmacological therapy in acromegaly.

@nl

prefLabel

The role of primary pharmacological therapy in acromegaly.

@en

The role of primary pharmacological therapy in acromegaly.

@nl

P1433

Q37531005-A2C8B51F-FCE3-42F8-B4D0-D82E40E1E153

P1476

Q37531005-1E664347-2CB1-4ABD-9531-BA263D085169

P2093

Q37531005-1E908A37-A827-45D7-8917-94757339DF46

Q37531005-3301650C-B4D8-49AB-9260-425AFDCA1D31

Q37531005-388824C3-AD0C-4384-AEDE-D61652377482

Q37531005-C2B3A3BF-AC2E-4D69-AE3A-17C895718806

Q37531005-C3798A02-2B37-4F8B-A14C-5E0780F0E082

Q37531005-D9F0D4D4-B992-4DDF-8E04-1E22DDBCC3D5

P2860

Q37531005-01B712AA-4D1D-4BD4-92E7-8D476CE35F66

Q37531005-082E22A1-15F8-4671-B3CA-59526772C024

Q37531005-103AA795-D650-44FE-99A9-644C25B969E8

Q37531005-154046AB-0203-4BFE-8F64-166C6B5CA675

Q37531005-24F34F75-90C7-4773-A549-09558EC3161D

Q37531005-2D485208-EC45-4706-A006-8DDA6AF7AC73

Q37531005-33CEEE04-D860-4C0E-9AFD-32A5FC122F0D

Q37531005-359B5C9D-1DFF-4F53-8404-D68CCE1D0C18

Q37531005-35F33E4B-8C0D-4CC4-A6C2-515CB3A2348B

Q37531005-370ED8E5-F359-45EF-ABC1-905A13BB4B9C

P2888

Q37531005-6C6F3871-33EA-437F-8909-AD56F8B8FAE2

P304

Q37531005-B5BEF3CF-C0D5-4188-A63E-7632D75F025D

P31

Q37531005-3AA5D538-F6E8-4CC0-AB4D-D501A92E67A9

P356

Q37531005-CFF49253-D915-488D-9D70-281FC731032D

P478

Q37531005-C589AB16-1EF0-4028-B1C4-F39F1D73300C

P577

Q37531005-DB6511DE-CAC3-4E33-99BF-EC1DE0795635

P5875

Q37531005-C730763A-143D-474E-A290-DE20E418A4A0

P698

Q37531005-16DDB7A4-A2AB-4DA2-926D-DB5546F4E0BF

P921

Q37531005-969C85C3-DE41-4B6A-9B4C-EC2AB1856332

P932

Q37531005-EB9E84B8-F43C-45CC-B1B0-2015A7F57292

P356

S11102-013-0530-0

P1433

P1476

The role of primary pharmacological therapy in acromegaly.

@en

P2093

Alfredo Adolfo Reza Albarrán

http://www.w3.org/2001/XMLSchema#string

Alin Abreu

http://www.w3.org/2001/XMLSchema#string

Ana Laura Espinosa de los Monteros

http://www.w3.org/2001/XMLSchema#string

Carmen A Carrasco

http://www.w3.org/2001/XMLSchema#string

Moisés Mercado

http://www.w3.org/2001/XMLSchema#string

Mônica Gadelha

http://www.w3.org/2001/XMLSchema#string

P2860

Acromegaly pathogenesis and treatment

Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study

Meta-analysis on the effects of octreotide on tumor mass in acromegaly

Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone.

Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review.

Management of acromegaly in Latin America: expert panel recommendations

Long-acting somatostatin analog therapy of acromegaly: a meta-analysis.

A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly.

Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs.

A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly.

P2888

s11102-013-0530-0

P304

S4-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11102-013-0530-0

http://www.w3.org/2001/XMLSchema#string

P478

17 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258117042

http://www.w3.org/2001/XMLSchema#string

P698

24166706

http://www.w3.org/2001/XMLSchema#string

P921

P932

3906545

http://www.w3.org/2001/XMLSchema#string